Browsing Tag
Hong Kong Exchanges and Clearing Limited
2 posts
Has Akeso Inc. just exposed the next weak spot in standard lung cancer treatment?
Find out how Akeso Inc.’s ivonescimab survival data could reshape lung cancer treatment and challenge PD-1 drug combinations.
NIO finally gave investors a profit signal, but China’s EV war is not done with $NIO yet
NIO’s Q1 revenue surged and deliveries jumped, but China’s slowing EV market keeps $NIO investors focused on margins, ES9 and execution.